Mizuho Medy Co Ltd
TSE:4595

Watchlist Manager
Mizuho Medy Co Ltd Logo
Mizuho Medy Co Ltd
TSE:4595
Watchlist
Price: 2 289 JPY -0.82% Market Closed
Market Cap: ¥34.4B

Operating Margin

37.6%
Current
Declining
by 10.7%
vs 3-y average of 48.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
37.6%
=
Operating Income
¥3.6B
/
Revenue
¥9.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
37.6%
=
Operating Income
¥3.6B
/
Revenue
¥9.7B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Mizuho Medy Co Ltd
TSE:4595
34.4B JPY
Loading...
US
Abbott Laboratories
NYSE:ABT
190.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...

Market Distribution

Higher than 96% of companies in Japan
Percentile
96th
Based on 6 730 companies
96th percentile
37.6%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Mizuho Medy Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
37.6%
=
Operating Income
¥3.6B
/
Revenue
¥9.7B
What is Mizuho Medy Co Ltd's current Operating Margin?

The current Operating Margin for Mizuho Medy Co Ltd is 37.6%, which is below its 3-year median of 48.3%.

How has Operating Margin changed over time?

Over the last 3 years, Mizuho Medy Co Ltd’s Operating Margin has decreased from 61.4% to 37.6%. During this period, it reached a low of 37.6% on Oct 30, 2025 and a high of 63.2% on Dec 31, 2022.

Back to Top